Opinion: First Opinion readers on cancer screening, mpox vaccines, and more
STAT
SEPTEMBER 7, 2024
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.
Let's personalize your content